Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -2.437% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CCC(C)NC(=O)Cn1cccc1C(=O)c1ccccc1
b Cc1ccccc1C(=O)N1CCN=C1SCc1ccc([N+](=O)[O-])cc1
c CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C.Cl
d Cc1ccc(OCCNC(=O)C2CC(=O)N(c3ccc(C)cc3)C2)cc1
Answer: a. CCC(C)NC(=O)Cn1cccc1C(=O)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)Cn1cccc1C(=O)c1ccccc1
CCC(C)NC(=O)Cn1cccc1C(=O)c1ccccc1
2-(2-benzoylpyrrol-1-yl)-N-butan-2-ylacetamide